BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8656838)

  • 21. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
    Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M
    Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin and learning and memory processes.
    Hadjiivanova C; Belcheva S; Belcheva I
    Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Child psychiatry and treatment with psychopharmaceuticals].
    Lund MA
    Ugeskr Laeger; 1976 Dec; 138(51):3285-6. PubMed ID: 996970
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholecystokinin and anxiety: promises and pitfalls.
    Rodgers RJ; Johnson NJ
    Crit Rev Neurobiol; 1995; 9(4):345-69. PubMed ID: 8829850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The future of biological psychiatry].
    Linnoila M
    Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128
    [No Abstract]   [Full Text] [Related]  

  • 27. [Involvement of the neuropeptide cholecystokinin in the mechanisms of regulation of emotions and craving].
    Anokhina IP; Proskuriakova TV
    Vestn Ross Akad Med Nauk; 2002; (6):36-40. PubMed ID: 12116760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 29. [Parenteral psychopharmaceuticals for agitated patients].
    Fruensgaard K
    Ugeskr Laeger; 1979 Jul; 141(28):1927-9. PubMed ID: 473416
    [No Abstract]   [Full Text] [Related]  

  • 30. [Psychopharmaceuticals in the treatment of disturbed behavior in epilepsy].
    Jorgić S; Pauković M
    Neurologija; 1982; 30(1-4):91-5. PubMed ID: 7187787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetics of psychotropic drugs].
    Predescu V; Costa D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(2):91-4. PubMed ID: 504847
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psychopharmaceuticals in general practice from the neurological and psychiatric viewpoint].
    Wieck HH; Zenglein R
    Z Allgemeinmed; 1975 Mar; 51(9):418-25. PubMed ID: 1163064
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy using psychopharmaceuticals (II)].
    Breithaupt H; Fellmann A
    Med Welt; 1978 Sep; 29(38):1471-4. PubMed ID: 692340
    [No Abstract]   [Full Text] [Related]  

  • 34. [Psychiatric nosology and indication of psychopharmaceuticals].
    Vinar O
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():114-8. PubMed ID: 829608
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
    Lesch KP; Beckmann H
    Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinazolinone cholecystokinin-B receptor ligands.
    Yu MJ; Thrasher KJ; McCowan JR; Mason NR; Mendelsohn LG
    J Med Chem; 1991 Apr; 34(4):1505-8. PubMed ID: 2016728
    [No Abstract]   [Full Text] [Related]  

  • 37. [Radioligand analysis of receptors on formed elements in the blood and perspectives for its use in psychiatry].
    Zozulja AA; Molcan J; Pacáková E
    Cesk Psychiatr; 1987 Jun; 83(3):167-72. PubMed ID: 2822263
    [No Abstract]   [Full Text] [Related]  

  • 38. [Selected psychopharmacotherapeutic problems in emergency psychiatric care].
    Tesarová O
    Cesk Psychiatr; 1983 Jun; 79(3):206-9. PubMed ID: 6883542
    [No Abstract]   [Full Text] [Related]  

  • 39. Brain endocoid identification as a strategy for the development of a new generation of psychoactive drugs.
    Costa E
    Prog Clin Biol Res; 1985; 192():29-36. PubMed ID: 3001758
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
    Griebel G; Holsboer F
    Nat Rev Drug Discov; 2012 May; 11(6):462-78. PubMed ID: 22596253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.